{{Rsnum
|rsid=4947972
|Gene=EGFR
|Chromosome=7
|position=55093350
|Orientation=plus
|GMAF=0.4109
|Gene_s=EGFR
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 10.8 | 35.4 | 53.8
| HCB | 75.6 | 24.4 | 0.0
| JPT | 76.7 | 18.6 | 4.7
| YRI | 0.0 | 4.8 | 95.2
| ASW | 0.0 | 0.0 | 0.0
| CHB | 75.6 | 24.4 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22552271
|Title=Integrated effect of EGFR and PAR-1 signaling crosstalk on airway hyperresponsiveness
}}{{PMID Auto
|PMID=19190167
|Title=A two-stage case-control study of EGFR polymorphisms and breast cancer risk.
|OA=1
}}